Abstract:Background Inhibition of tumor growth by endostatin has been shown to be an effective strategy in cancer therapy in mice. However, its widespread application has been hampered by difficulties in a large-scale production of the recombinant endostatin protein, rapid loss bioactivity of the protein, and the cumbersome daily administration. These limitations could be resolved by in vivo delivery and expression of the endostatin gene. In this study, we observed the effect and advantage of endostatin gene therapy mediated by a recombinant adenoviral vector (Ad/hEndo) on the growth of hepatocellular carcinoma BEL-7402 xenografted tumors, comparison with recombinant endostatin protein.Results After 4 courses of treatment, the tumor growth rates of high-dose treated group with 1×109 pfu of Ad/hEndo were inhibited by 42.26% compared with the Ad/LacZ control group (P=0.001) and by 46.26% compared with the NIH buffer control group (P=0.003), respectively. However, in this study, Ad/hEndo at low dose of 5×108 pfu failed to demonstrate significant inhibition of tumor growth, compared with control groups. After daily administration of recombinant human endostatin protein (rhEndo) for 9 days, the ratio of T/C (rhEndo group versus PBS group) was less than 47%. However, two days after rhEndo treatment ceased, the ratio of T/C was more than 50%. The peak of expression of endostatin mRNA in tumor tissue was at 2 or 3 days after administration intratumorally with Ad/hEndo of 1×109 pfu and gradually dropped undetectable by day 7. Dynamic analysis of endostatin concentration in tumor tissue showed that the highest level of mRNA is up at the third day after injection, and dropped to basal level three weeks later.Conclusions Endostatin gene therapy mediated by a recombinant adenoviral vector had significantly inhibited the growth of hepatocellular carcinoma BEL-7402 xenografted tumors at a high dose of 1×109 pfu compared with other groups. The analysis of dynamic expression of endostatin in vivo indicated that Ad/hEndo had acquired a

High-level expression and secretion of recombinant mouse endostatin by Escherichia coli

Expression of soluble, biologically active recombinant human endostatin in Escherichia coli

Molecular cloning, expression and purification of recombinant soluble mouse endostatin as an anti-angiogenic protein in Escherichia coli

High Efficient Expression of Human Endostatin in E.coli and Its Antiangiogensis Activity

Expression and Purification of Soluble Recombinant Human Endostatin in Escherichia Coli

High level expression of human endostatin in Pichia pastoris using a synthetic gene construct

Prokaryotic Expression of Endostat in and Preparation of Polyclonal Antibody

EXPRSSION OF HUMAN ENDOSTATIN IN PICHIA PASTORIS

Inhibition of Tumor Growth in Mice by Endostatin Derived from Abdominal Transplanted Encapsulated Cells

Expression of Human Endostatin in Larvae of Silkworm (bombyx Mori) and in Vitro Activity Assays.

Construction and Application of Recombinant Adenovirus Vector Expressing the Mouse Endostatin

Cloning, Expression and Tumor Suppression of Human Endostatin.

Construction of Prokaryotic Expression Vector Pflag-Ssendostatin with Mouse Secretion Type Endostatin

Constitutive Expression of Human Endostatin in Pichia Pastoris and Bioactivity Assay

Dynamic Distribution and Expression in Vivo of Human Endostatin Gene Delivered by Adenoviral Vector.

Expression of recombinant 32 000 doliton polypeptide of mouse enamelin in Escherichia coli and its purification

Construction of Pegr-Ssendostatin and Mouse Endostatin Expression in Vitro Induced by Ionizing Radiation

Bioactivity and Stability Analysis of Endostatin Purified from Fermentation Supernatant of 293 Cells Transfected with Ad/rhEndo.

Inhibition of Tumor Growth in Xenografted Nude Mice with Adenovirus-Mediated Endostatin Gene Comparison with Recombinant Endostatin Protein.

[Optimization of fermentation of recombinant human Endostatin (rh-Endostatin) expression in Escherichia coli]

Refolding and Purification of Recombined Human Endostatin Using Cation Exchange Chromatography